18th EBF Open Symposium
18 - 20 November, 2025
Barcelona, Spain
Visit us at BOOTH 3C
Request a meeting with our on-site team to learn how we help our clients advance their therapeutic drug programs.
BioAgilytix will be presenting...
.jpeg?width=400&height=371&name=Janett%20Schwarz%20(2).jpeg)
Scientific Operations
Tuesday, 18 November
12:30 - 12:50
Session 3: The wonderful world of NBE – applications
%20(2).jpg?width=400&height=374&name=Ellen%20Gattkowski%20(1)%20(2).jpg)
Scientific Operations
Wednesday, 19 November
11:20 – 13:00
Workshop 3: Kits and reagent bridging
.jpeg?width=400&height=379&name=Lynn_Kamen_22D7421_Web%20(2).jpeg)
Subtitle: Presented by Lynn Kamen on behalf of the NAb Team in the AAPS BioAnalytical Community
Scientific Officer
Wednesday, 19 November
10:20 – 10:40
Session 11: General ADA/Nab
.jpeg?width=400&height=392&name=Dave_Beyerlein%20(2).jpeg)
Scientific Operations
Wednesday, 19 November
12:20 – 12:40
Session 13: ADC

Scientific Operations
Thursday, 20 November
11:50 – 12:10
Session 19: 1-Tier Tech

Scientific Operations
Thursday, 20 November
15:00 – 15:20
Session 21: 1-Tier: Strategic discussions
.jpeg?width=400&height=400&name=Marco%20Klinge_edit%20(1).jpeg)
Scientific Operations
Poster times:
Tuesday, 18 November from 12:50 – 14:00 + 15:40 – 16:20
Wednesday, 19 November from 10:40 – 11:20, 13:00 – 14:00 + 15:40 – 16:20
Thursday, 20 November from 10:20 – 11:10 + 12:50 – 14:00
Customized approaches to support your bioanalytical needs
BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. We offer the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing in a GxP environment. Our lab services include immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, eliminating the need for multiple providers, ensuring efficient data delivery for your therapeutic study.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies. Its goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and regulatory issues in Bioanalysis. Until 2010, EBF membership was limited to pharmaceutical R&D companies with bioanalytical activities in Europe. From 2011 onwards, the EBF welcomed CROs having regulated BioA lab-activities in Europe. In 2010, the EBF registered as a non-profit organization (vzw) (the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations. The EBF non-profit organization was integrated into the Belgian Code on Companies and Associations (the BCCA) in 2023.
Learn more about this event on their website.

Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2026 BioAgilytix Labs. All rights reserved.